A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: A RTOG randomized study (#79-04)

✍ Scribed by Ding-Jen Lee; Thomas F. Pajak; Joanne Stetz; Stanley E. Order; Joseph B. Weissberg; James J. Fischer

• Book ID: 107963693
• Publisher: Elsevier Science
• Year: 1989
• Tongue: English
• Weight: 675 KB
• Volume: 16
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/0360-3016(89)90343-x